Strong Dollar, Weak Performance: Big Pharma Is An Industry Adrift
This article was originally published in Scrip
Executive Summary
On the face of it, the latest quarterly results from the 10 biggest drug companies indicate that eight of them will have lower drug sales in 2015 than in 2014. The mood music behind the Q3 numbers is wistful and selective, suggesting that some of the biggest names in the industry are not sure where they are going even though they know that they don't really want to start from here.